AI Assistant
Blog
Pricing
Log In
Sign Up
The DAPA-HF trial marks the beginning of a new era in the treatment of heart failure with reduced ejection fraction
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
